165
Views
21
CrossRef citations to date
0
Altmetric
Reviews

Advances in LC platforms for drug discovery

, PhD, , PhD, , PhD, , , & , PhD show all
Pages 475-489 | Published online: 05 Apr 2010

Bibliography

  • Bleicher KH, Bohm HJ, Muller K, Alanine AI. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2003;2:369-78
  • Mayr LM, Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol 2009;9:580-8
  • Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005;4:206-20
  • Smith DA, van de Waterbeemd H. Pharmacokinetics and metabolism in early drug discovery. Curr Opin Chem Biol 1999;3:373-8
  • Kerns EH, Di L. Pharmaceutical profiling in drug discovery. Drug Discov Today 2003;8:316-23
  • Korfmacher WA. Principles and applications of LC-MS in new drug discovery. Drug Discov Today 2005;10:1357-67
  • Wolfender JL, Queiroz EF, Hostettman K. The importance of hyphenated techniques in the discovery of new lead compounds from nature. Expert Opin Drug Discov 2006;1:237-60
  • Shin YG, van Breemen RB. Analysis and screening of combinatorial libraries using mass spectrometry. Biopharm Drug Dispos 2001;22:353-72
  • Mallis LM, Sarkahian AB, Kulishoff JM, Watts WL. Open-access liquid chromatography/mass spectrometry in a drug discovery environment. J Mass Spectrom 2002;37:889-96
  • Kassel DB. Applications of high-throughput ADME in drug discovery. Curr Opin Chem Biol 2004;8:339-45
  • Kerns EH. High throughput physicochemical profiling for drug discovery. J Pharm Sci 2001;90:1838-58
  • Henchoz Y, Bard B, Guillarme D, Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution. Anal Bioanal Chem 2009;394:707-29
  • Martel S, Guillarme D, Henchoz Y, Chromatographic approaches for measuring logP. In: Mannhold R, editor, Molecular drug properties: measurement and computation. Wiley-VCH, 2008
  • Russo R, Guillarme D, Nguyen DT, Pharmaceutical applications on columns packed with sub-2μm particles. J Chromatogr Sci 2008;46:199-208
  • Nguyen DT, Guillarme D, Rudaz S, Veuthey JL. Chromatographic behaviour and comparison of column packed with sub-2μm stationary phases in liquid chromatography. J Chromatogr A 2006;1128:105-13
  • McCalley DV. Evaluation of the properties of a superficially porous silica stationary phase in hydrophilic interaction chromatography. J Chromatogr A 2008;1193:85-91
  • Cunliffe JM, Maloney TD. Fused-core particle technology as an alternative to sub-2μm particles to achieve high separation efficiency with low backpressure. J Sep Sci 2007;30:3104-9
  • MacNair JE, Patel KD, Jorgenson JW. Ultrahigh-pressure reversed-phase capillary liquid chromatography: isocratic and gradient elution using columns packed with 1.0μm particles. Anal Chem 1999;71:700-8
  • Guillarme D, Russo R, Rudaz S, Chromatographic performance of silica-based stationary phases in high temperature liquid chromatography: pharmaceutical applications. Curr Pharm Anal 2007;4:221-9
  • Cabrera K. Applications of silica-based monolithic HPLC columns. J Sep Sci 2004;27:843-52
  • Nguyen DT, Guillarme D, Rudaz S, Veuthey JL. Fast analysis in liquid chromatography using small particle size and high pressure. J Sep Sci 2006;29:1836-48
  • Mazzeo JR, Neue UD, Kele M, Plumb RS. A new separation technique takes advantage of sub-2-μm porous particles. Anal Chem 2005;77:460A-7A
  • Swartz ME. UPLC: an introduction and review. J Liq Chromatogr Relat Technol 2005;28:1253-63
  • Guillarme D, Nguyen DT, Rudaz S, Veuthey JL. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part I: isocratic separation. Eur J Pharm Biopharm 2007;66:475-82
  • Guillarme D, Nguyen DT, Rudaz S, Veuthey JL. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part II: gradient experiments. Eur J Pharm Biopharm 2008;68:430-40
  • Guillarme D, Grata E, Glauser G, Some solutions to obtain very efficient separations in isocratic and gradient modes using small particles size and ultra-high pressure. J Chromatogr A 2009;1216:3232-43
  • Grata E, Guillarme D, Glauser G, Metabolite profiling of plant extracts by ultra-high-pressure liquid chromatography at elevated temperature coupled to time-of-flight mass spectrometry. J Chromatogr A 2009;1216:5660-8
  • Tolonen A, Turpeinen M, Pelkonen O. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Drug Discov Today 2009;14:120-33
  • Howard ML, Hill JJ, Galluppi GR, McLean MA. Plasma Protein Binding in Drug Discovery and Development. Comb Chem High Throughput Screen 2009;13(2)170-87
  • Triolo A, Altamura M, Cardinali F, Mass spectrometry and combinatorial chemistry: a short outline. J Mass Spectrom 2001;36:1249-59
  • Wang T, Cohen J, Kassel DB, Zeng L. A multiple electrospray interface for parallel mass spectrometric analyses of compound libraries. Comb Chem High Throughput Screen 1999;2:327-34
  • Feher M, Schmidt JM. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 2003;43:218-27
  • Lin Y, Schiavo S, Orjala J, Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Anal Chem 2008;80:8045-54
  • Abel U, Koch C, Speitling M, Hansske FG. Modern methods to produce natural-product libraries. Curr Opin Chem Biol 2002;6:453-8
  • Liu L, Li YF, Cheng YY. A method for the production and characterization of fractionated libraries from Chinese herbal formulas. J Chromatogr B 2008;862:196-204
  • Glauser G, Guillarme D, Grata E, Optimized liquid chromatography-mass spectrometry approach for the isolation of minor stress biomarkers in plant extracts and their identification by capillary nuclear magnetic resonance. J Chromatogr A 2008;1180:90-8
  • Grata E, Boccard J, Guillarme D, UPLC-TOF-MS for plant metabolomics: a sequential approach for wound marker analysis in Arabidopsis thaliana. J Chromatogr B 2008;871:261-70
  • Quinn RJ, Carroll AR, Pham NB, Developing a drug-like natural product library. J Nat Prod 2008;71:464-8
  • Konkimalla VB, Efferth T. Anti-Cancer Natural Product Library from Traditional Chinese Medicine. Comb Chem High Throughput Screen 2008;11:7-15
  • Faller B, Grimm HP, Loeuillet-Ritzler F, High-throughput lipophilicity measurement with immobilized artificial membranes. J Med Chem 2005;48:2571-6
  • Carrara S, Reali V, Misiano P, Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison. Int J Pharm 2007;345:125-33
  • Mensch J, Noppe M, Adriaensen J, Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early drug discovery. J Chromatogr B 2007;847:182-7
  • Nasal A, Kaliszan R. Progress in the use of HPLC for evaluation of lipophilicity. Curr Comput Aided Drug Des 2006;2:327-40
  • Poole SK, Poole CF. Separation methods for estimating octanol-water partition coefficients. J Chromatogr B 2003;797:3-19
  • Stella C, Galland A, Liu X, Novel RPLC stationary phases for lipophilicity measurement: solvatochromic analysis of retention mechanisms for neutral and basic compounds. J Sep Sci 2005;28:2350-62
  • Stella C, Seuret P, Rudaz S, Characterization of chromatographic supports for the analysis of basic compounds. J Sep Sci 2002;25:1351-63
  • Liu X, Tanaka H, Yamauchi A, Lipophilicity measurement by reversed-phase high-performance liquid chromatography (RP-HPLC): a comparison of two stationnary phases based on retention mechanisms. Helv Chim Acta 2004;87:2866-76
  • Liu X, Tanaka H, Yamauchi A, Determination of lipophilicity by reversed-phase high-performance liquid chromatography. Influence of 1-octanol in the mobile phase. J Chromatogr A 2005;1091:51-9
  • Benhaim D, Grushka E. Effect of n-octanol in the mobile phase on lipophilicity determination by reversed-phase high-performance liquid chromatography on a modified silica column. J Chromatogr A 2008;1209:111-9
  • Liu X, Hefesha H, Tanaka H, Lipophilicity measurement of drugs by reversed phase HPLC over wide pH range using an alkaline-resistant silica-based stationary phase, XBridge Shield RP(18). Chem Pharm Bull 2008;56:1417-22
  • Bard B, Carrupt PA, Martel S. Lipophilicity of basic drugs measured by hydrophilic interaction chromatography. J Med Chem 2009;52:3416-9
  • Valko K, My Du C, Bevan C, Rapid method for the estimation of octanol/water partition coefficient (Log Poct) from gradient RP-HPLC retention and a hydrogen bond acidity term (Σa2H)). Curr Med Chem 2001;8:1137-46
  • Ayouni L, Cazorla G, Chaillou D, Fast determination of lipophilicity by HPLC. Chromatographia 2005;62:251-5
  • Donovan SF, Pescatore MC. Method for measuring the logarithm of the octanol-water partition coefficient by using short octadecyl-poly(vinyl alcohol) high-performance liquid chromatography columns. J Chromatogr A 2002;952:47-61
  • Welerowicz T, Buszewski B. The effect of stationary phase on lipophilicity determination of beta-blockers using reverse-phase chromatographic systems. Biomed Chromatogr 2005;19:725-36
  • Henchoz Y, Guillarme D, Rudaz S, High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists. J Med Chem 2008;51:396-9
  • Guillot A, Henchoz Y, Moccand C, Lipophilicity determination of highly lipophilic compounds by liquid chromatography. Chem Biodivers 2009;6:1828-36
  • Camurri G, Zaramella A. High-throughput liquid chromatography/mass spectrometry method for the determination of the chromatographic hydrophobicity index. Anal Chem 2001;73:3716-22
  • Zhao Y, Jona J, Chow DT, High-throughput logP measurement using parallel liquid chromatography/ultraviolet/mass spectrometry and sample-pooling. Rapid Commun Mass Spectrom 2002;16:1548-55
  • Kerns EH, Di L, Petusky S, Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography-mass spectrometry. J Chromatogr B 2003;791:381-8
  • Wan H, Ulander J. High-throughput pKa screening and prediction amenable for ADME profiling. Expert Opin Drug Metab Toxicol 2006;2:139-55
  • Kaliszan R, Wiczling P, Markuszewski MJ. pH gradient high-performance liquid chromatography: theory and applications. J Chromatogr A 2004;1060:165-75
  • Chiang PC, Hu Y. Simultaneous Determination of LogD, LogP, and pKa of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injector. Comb Chem High Throughput Screen 2009;12:250-7
  • Escuder-Gilabert L, Martinez-Pla JJ, Sagrado S, Biopartitioning micellar separation methods: modelling drug absorption. J Chromatogr B 2003;797:21-35
  • Taillardat-Bertschinger A, Carrupt PA, Barbato F, Testa B. Immobilized artificial membrane HPLC in drug research. J Med Chem 2003;46:655-65
  • Kotecha J, Shah S, Rathod I, Subbaiah G. Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors. Int J Pharm 2008;360:96-106
  • Yoon CH, Kim SJ, Shin BS, Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography. J Biomol Screen 2006;11:13-20
  • De Jager M, Groenink W, Guivernau R, A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives. Pharm Res 2006;23:951-60
  • Osterberg T, Svensson M, Lundahl P. Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids. Eur J Pharm Sci 2001;12:427-39
  • Molero-Monfort M, Escuder-Gilabert L, Villanueva-Camanas RM, Biopartitioning micellar chromatography: an in vitro technique for predicting human drug absorption. J Chromatogr B 2001;753:225-36
  • Escuder-Gilabert L, Molero-Monfort M, Villanueva-Camanas RM, Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier. J Chromatogr B 2004;807:193-201
  • Martin-Biosca Y, Molero-Monfort M, Sagrado S, Rapid in vitro test to predict ocular tissue permeability based on biopartitioning micellar chromatography. Eur J Pharm Sci 2003;20:209-16
  • Lu R, Sun J, Wang Y, Characterization of biopartitioning micellar chromatography system using monolithic column by linear solvation energy relationship and application to predict blood-brain barrier penetration. J Chromatogr A 2009;1216:5190-8
  • Yan Z, Caldwell GW. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr Top Med Chem 2001;1:403-25
  • Caldwell GW, Yan Z, Tang W, ADME optimization and toxicity assessment in early- and late-phase drug discovery. Curr Top Med Chem 2009;9:965-80
  • Baranczewski P, Stanczak A, Sundberg K, Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol Rep 2006;58:453-72
  • Nicoli R, Bartolini M, Rudaz S, Development of immobilized enzyme reactors based on human recombinant cytochrome P450 enzymes for phase I drug metabolism studies. J Chromatogr A 2008;1206:2-10
  • Nicoli R, Curcio R, Rudaz S, Veuthey JL. Development of an in-capillary approach to nanoscale automated in vitro cytochromes p450 assays. J Med Chem 2009;52:2192
  • Krylova SM, Okhonina V, Evenhuis CJ, Krylov SN. The Inject-Mix-React-Separate-and-Quantitate (IMReSQ) approach to studying reactions in capillaries. Trends Anal Chem 2009;28:987-1010
  • Plumb RS, Potts WB, Rainville PD, Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies. Rapid Commun Mass Spectrom 2008;22:2139-52
  • Tiller PR, Romanyshyn LA. Liquid chromatography/tandem mass spectrometric quantification with metabolite screening as a strategy to enhance the early drug discovery process. Rapid Commun Mass Spectrom 2002;16:1225-31
  • Hop CE, Tiller PR, Romanyshyn L. In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry. Rapid Commun Mass Spectrom 2002;16:212-9
  • Guillarme D, Schappler J, Rudaz S, Veuthey JL. Coupling ultra-high pressure liquid chromatography with mass spectrometry. Trend Anal Chem 2010;29:15-27
  • Novakova L, Vlckova H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal Chim Acta 2009;656:8-35
  • Xu R, Manuel M, Cramlett J, Kassel DB. A high-throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry. J Chromatogr A 2010;1217(10):1616-25
  • Yu K, Di L, Kerns E, Ultra-performance liquid chromatography/tandem mass spectrometric quantification of structurally diverse drug mixtures using an ESI-APCI multimode ionization source. Rapid Commun Mass Spectrom 2007;21:893-902
  • Schappler J, Nicoli R, Nguyen D, Coupling ultra high-pressure liquid chromatography with single quadrupole mass spectrometry for the analysis of a complex drug mixture. Talanta 2009;78:377-87
  • Rainville PD, Wheaton JP, Alden PG, Plumb RS. Sub one minute inhibition assays for the major cytochrome P450 enzymes utilizing ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2008;22:1345-50
  • Song W, Pabbisetty D, Groeber EA, Comparison of fused-core and conventional particle size columns by LC-MS/MS and UV: application to pharmacokinetic study. J Pharm Biomed Anal 2009;50:491-500
  • Chauve B, Guillarme D, Cleon P, Veuthey JL. Evaluation of various HILIC materials for the fast separation of polar compounds. J Sep Sci 2010;33:1-13
  • Nguyen HP, Schug KA. The advantages of ESI-MS detection in conjunction with HILIC mode separations: Fundamentals and applications. J Sep Sci 2008;31:1465-80
  • Plumb R, Castro-Perez J, Granger J, Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2004;18:2331-7
  • Tiller PR, Yu S, Castro-Perez J, High-throughput, accurate mass liquid chromatography/tandem mass spectrometry on a quadrupole time-of-flight system as a ‘first-line’ approach for metabolite identification studies. Rapid Commun Mass Spectrom 2008;22:1053-61
  • Castro-Perez J, Plumb R, Granger JH, Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 2005;19:843-8
  • Crockford DJ, Maher AD, Ahmadi KR, 1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies. Anal Chem 2008;80:6835-44
  • Bateman KP, Castro-Perez J, Wrona M, MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun Mass Spectrom 2007;21:1485-96
  • Noga M, Sucharski F, Suder P, Silberring J. A practical guide to nano-LC troubleshooting. J Sep Sci 2007;30:2179-89
  • Yin H, Killeen K, Brennen R, Microfluidic chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip. Anal Chem 2005;77:527-33
  • Vollmer M, Buckenmaier S. Using nanospray HPLC-CHIP/TOF for routine high sensitivity metabolite identification. Agilent technologies application note. 2006:5989-5938EN
  • Guillarme D, Ruta J, Rudaz S, Veuthey JL. New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches: published online, doi: 10 1007/s00216-009-3305-8 2010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.